Targeting Cardiovascular Diseases by Flavonols: An Update

Area of Science:

• Nutritional Biochemistry
• Cardiovascular Pharmacology

Background:

• Flavonols are abundant natural compounds and popular dietary supplements.
• In vitro and in vivo studies suggest cardioprotective effects of flavonols, particularly quercetin.
• Key mechanisms include antiatherogenic, antithrombotic, and antioxidant activities, alongside vasodilation and apoptosis regulation.

Purpose of the Study:

• To review recent clinical data on flavonol intake and cardiovascular effects.
• To clarify the role of flavonol supplementation in cardiovascular health.
• To aid clinicians in understanding flavonol's value for at-risk individuals and patients.

Main Methods:

• Systematic review of randomized controlled trials and meta-analyses.
• Analysis of recent clinical data on human cardiovascular parameters.
• Focus on studies investigating flavonol supplementation.

Main Results:

• Experimental studies indicate significant cardioprotective potential of flavonols.
• Clinical trials and meta-analyses show inconsistent results regarding human cardiovascular outcomes.
• Further investigation is needed to reconcile experimental findings with clinical evidence.

Conclusions:

• Flavonol supplementation's impact on cardiovascular health requires further clarification.
• The review highlights the need for more consistent clinical data.
• Clinicians should consider the current evidence base when advising on flavonol supplements for cardiovascular health.